← Database
GHRH Analog

Sermorelin

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

Has a longer clinical history than most secretagogues, including diagnostic use in evaluating GH secretion; availability has varied.

How it works

Sermorelin is the shortest active fragment of GHRH — just the first 29 amino acids — and it does the same basic job: it tells the pituitary to release the body's own growth hormone.

When it binds the pituitary's GHRH receptors it triggers a burst of GH while leaving the natural pulse-and-feedback system intact. That preserved physiology is part of why it was historically used as a diagnostic: give sermorelin, then measure the GH response to gauge how much reserve the pituitary has.

Its half-life is only minutes, so any effect is brief, and its use depends on that short, sharp stimulus. Its commercial availability has come and gone over the years, and the GH response can be blunted by the body's opposing hormone, somatostatin.

Mechanism · Detailed Analysis
Molecular targetGHRH(1-29) — the minimal active fragment of GHRH — binding pituitary GHRH receptors.
Signaling & downstream effectsTriggers transient GH pulses while preserving pulsatility and negative feedback.
PharmacokineticsVery short half-life (minutes), so the effect is brief; historically dosed for diagnostic GH-stimulation testing.
CaveatsGH response is blunted by somatostatin tone; product availability has varied over time.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.